+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Neglected Tropical Diseases Diagnosis - Global Market Trajectory & Analytics

  • ID: 5303655
  • Report
  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter/Danaher
  • Coris Bioconcept SPRL
  • F. Hoffmann-La Roche Ltd.
  • Life Technology
  • Oscar Medicare Pvt Ltd.
  • MORE
Global Neglected Tropical Diseases Diagnosis Market to Reach $7.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Neglected Tropical Diseases Diagnosis estimated at US$6 Billion in the year 2020, is projected to reach a revised size of US$7.9 Billion by 2027, growing at a CAGR of 4% over the period 2020-2027. Conventional, one of the segments analyzed in the report, is projected to record 3.7% CAGR and reach US$4.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Molecular / Modern segment is readjusted to a revised 4.4% CAGR for the next 7-year period.



The U.S. Market is Estimated at $1.6 Billion, While China is Forecast to Grow at 6.4% CAGR

The Neglected Tropical Diseases Diagnosis market in the U.S. is estimated at US$1.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 6.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.4% and 3.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Select Competitors (Total 33 Featured):
  • Abbott Laboratories
  • Beckman Coulter/Danaher
  • Bio-Rad Laboratories, Inc.
  • Coris Bioconcept SPRL
  • DiaSys Diagnostic Systems GmbH
  • F. Hoffmann-La Roche Ltd.
  • Genome Diagnostics Pvt. Ltd
  • InBios International, Inc.
  • Life Technology
  • Novartis Diagnostics., Ltd.
  • Omega Diagnostics Group PLC
  • Ortho-Clinical Diagnostics
  • Oscar Medicare Pvt Ltd.
  • Premier Medical Corporation Ltd.
  • Siemens Healthcare
  • Thermo Fisher Scientific, Inc.
  • Wako Chemicals, Inc.
  • ZeptoMetrix
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter/Danaher
  • Coris Bioconcept SPRL
  • F. Hoffmann-La Roche Ltd.
  • Life Technology
  • Oscar Medicare Pvt Ltd.
  • MORE
I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS
  • UNITED STATES
  • CANADA
  • JAPAN
  • CHINA
  • EUROPE
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • SPAIN
  • RUSSIA
  • REST OF EUROPE
  • ASIA-PACIFIC
  • AUSTRALIA
  • INDIA
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • ARGENTINA
  • BRAZIL
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA
IV. COMPETITION
  • Total Companies Profiled: 33
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Beckman Coulter/Danaher
  • Bio-Rad Laboratories, Inc.
  • Coris Bioconcept SPRL
  • DiaSys Diagnostic Systems GmbH
  • F. Hoffmann-La Roche Ltd.
  • Genome Diagnostics Pvt. Ltd
  • InBios International, Inc.
  • Life Technology
  • Novartis Diagnostics. Ltd.
  • Omega Diagnostics Group PLC
  • Ortho-Clinical Diagnostics
  • Oscar Medicare Pvt Ltd.
  • Premier Medical Corporation Ltd.
  • Siemens Healthcare
  • Thermo Fisher Scientific, Inc.
  • Wako Chemicals, Inc.
  • ZeptoMetrix
Note: Product cover images may vary from those shown
Adroll
adroll